Key features and details | |
Cat. No. | MABL-3000 |
Name | Anti-TACE mAbs |
Clone No. | AFD- D1 (A12) |
From | Recombinant Antibody |
Isotype | Engineer antibody |
Application | Block |
Species Reactivity | Human |
Basic Information | |
Specificity | This antibody binds human (not mouse) TACE catalytic and non-catalytic domains. |
Alternative Name | ADAM17; tumor necrosis factor-α-converting enzyme; CD156b |
UniProt | P78536 |
Immunogen | Recombinant human ADAM17 (TACE) ectodomain tagged to biotin. |
Application Notes | TACE (CD156b) has proved capable of cleaving epidermal growth factor receptor (EGFR) ligands, extracellular Notch1, cell-surface receptors, and adhesion molecules. As proteolytic cleavage is an indispensable activation event for many of these substrates, TACE has emerged as an attractive therapeutic target for the treatment of cancer and rheumatoid arthritis. This “cross-domain” human antibody is a selective TACE antagonist and provides a unique alternative to smallmolecule metalloprotease inhibition. Note from inventor: "D1(A12) is conformation sensitive and sees only a specific form of the native enzyme (reflecting its redox state). It does not work by IHC or WB. It was designed as a potential drug, active in native situations". |
Antibody First Published | Tape et al. Cross-domain inhibition of TACE ectodomain Proc Natl Acad Sci U S A. 108(14):5578-83 PMID:21415364 |
Note on publication | Describes the generation and characterisation of this antibody by phage-display. |
COA Information (For reference only, actual COA shall prevail) | |
Size | 100 μg Purified antibody. |
Concentration | 1 mg/ml. |
Purification | Protein A affinity purified |
Buffer | PBS with 0.02% Proclin 300. |
Concentration | 1 mg/ml. |
Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. |